Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824973) titled 'Ketamine Treatment for Treatment-Resistant Depression - the Role of Framing' on Sept. 11.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).

Primary Sponsor: Valdemar Landgren

Condition: Treatment Resistant Depression (TRD)

Intervention: Behavioral: Psychedelic framing

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: September 2026

Target Sample Size: 120

Countries of Recruitment: Sweden

To know more, visit https://clinicaltrials.gov/study/NCT07824973

Disclai...